Ravels, Belgium

Gaston S Diels

This inventor holds 21 USPTO granted patents and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 1987-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gaston S Diels. Retrieved from https://idiyas.com/inventor/gaston-s-diels

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.6

ph-index = 8

Forward Citations = 313(Granted Patents)


Location History:

  • Ravels, BE (1987 - 2003)
  • Beerse, BE (2021 - 2024)

Company Filing History:


Years Active: 1987-2024

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Gaston S. Diels in Pharmaceutical Patents

Introduction

Gaston S. Diels, based in Ravels, Belgium, is a notable inventor in the pharmaceutical field, with an impressive portfolio of 21 patents. His work primarily focuses on compounds that have significant implications in treating various diseases and disorders, particularly through the modulation of MALT1.

Latest Patents

One of Diels' most recent patents, titled "Pyrazole Derivatives as MALT1 Inhibitors," describes a range of compounds, compositions, and methods specifically aimed at addressing diseases, syndromes, conditions, and disorders influenced by MALT1 modulation. These compounds are represented by a unique formula, showcasing the innovative thinking and research efforts put forth by Diels and his team.

Career Highlights

Gaston S. Diels is associated with Janssen Pharmaceutica NV, a world-renowned company recognized for its contributions to the pharmaceutical industry. His role at the company allows him to leverage cutting-edge research and development processes to drive potential therapeutic advancements.

Collaborations

Throughout his career, Diels has worked alongside esteemed colleagues, including Frans E. Janssens and Joseph L. Torremans. This collaborative environment fosters a rich exchange of ideas and accelerates the development of groundbreaking inventions in the pharmaceutical domain.

Conclusion

Gaston S. Diels exemplifies innovation in the pharmaceutical sector, particularly through his work with pyrazole derivatives and MALT1 inhibitors. His contributions not only enhance the understanding of key biological processes but also pave the way for new therapeutic strategies in the treatment of various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…